Hidden risks associated with conventional short intermittent hemodialysis: A call for action to mitigate cardiovascular risk and morbidity

doi:10.5527/wjn.v11.i2.39

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8493)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

456

WORD

139

HTML

5673

Figures (1-3)

263

Sum=6531

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

260

Download

724

Sum=984

Publishing Process of This Article

Item

Count

Browse

326

Download

652

Sum=978

Mar 25, 2022 (publication date) through Dec 4, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Nephrol. Mar 25, 2022; 11(2): 39-57
Published online Mar 25, 2022. doi: 10.5527/wjn.v11.i2.39

Full Size Figure Download Figure

Figure 3 Action plan to design and implement a more cardioprotective renal replacement treatment in order to improve patient outcomes. HD: Hemodialysis; PBUT: Protein bound uremic toxins; LMW: Low-molecular-weight; HMW: High-molecular-weight; HDF: On-line hemodiafiltration.

Citation: Canaud B, Kooman JP, Selby NM, Taal M, Maierhofer A, Kopperschmidt P, Francis S, Collins A, Kotanko P. Hidden risks associated with conventional short intermittent hemodialysis: A call for action to mitigate cardiovascular risk and morbidity. World J Nephrol 2022; 11(2): 39-57
URL: https://www.wjgnet.com/2220-6124/full/v11/i2/39.htm
DOI: https://dx.doi.org/10.5527/wjn.v11.i2.39